Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Controlled sedation with alphaxalone-alphadolone.

M A Ramsay, T M Savege, B R Simpson

    British Medical Journal
    |June 22, 1974
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Evaluation of the First Contact Physiotherapy (FCP) model of primary care: patient characteristics and outcomes.

    Physiotherapy·2021
    Same author

    Evaluation of the First Contact Physiotherapy (FCP) model of primary care: a qualitative insight.

    Physiotherapy·2021
    Same author

    A UK-wide survey looking at teaching and trainee confidence in teledermatology: a vital gap in a COVID-19-induced era of rapid digital transformation?

    Clinical and experimental dermatology·2020
    Same author

    Eastern Canadian Gastrointestinal Cancer Consensus Conference 2018.

    Current oncology (Toronto, Ont.)·2019
    Same author

    Try to see it my way: exploring the co-design of visual presentations of wellbeing through a workshop process.

    Perspectives in public health·2019
    Same author

    Hypertension as a predictor of advanced colorectal cancer outcome and cetuximab treatment response.

    Current oncology (Toronto, Ont.)·2019
    Same journal

    Muscular pain during therapy with carbenoxolone (Biogastrone).

    British medical journal·2016
    Same journal

    ACUTE INTESTINAL OBSTRUCTION DUE TO INTRA-ABDOMINAL CAUSES.

    British medical journal·2014
    Same journal

    A CASE OF HAEMATIDROSIS.

    British medical journal·2014
    Same journal

    Incidence of ulcer in haematemesis.

    British medical journal·2011
    Same journal

    Pituitary hypothyroidism with impaired renal function.

    British medical journal·2011
    Same journal

    The fenestration operation for otosclerosis.

    British medical journal·2011
    See all related articles

    Controlled infusion of alphaxalone-alphadolone (Althesin) provided effective sedation in intensive care, allowing precise control and rapid adjustments. This method proved safe and reliable, even for prolonged use up to 20 days.

    Area of Science:

    • Anesthesiology
    • Critical Care Medicine

    Background:

    • Sedation management in intensive therapy units (ITUs) is crucial for patient comfort and clinical procedures.
    • Alphaxalone-alphadolone (Althesin) is an anesthetic agent with potential sedative properties.

    Purpose of the Study:

    • To evaluate the efficacy and safety of diluted alphaxalone-alphadolone administered as a controlled infusion for sedation in ITU patients.
    • To assess the controllability and clinical utility of this sedation technique.

    Main Methods:

    • Alphaxalone-alphadolone was administered as a controlled infusion to 30 intensive therapy unit patients.
    • The level of sedation was rapidly and accurately controlled.
    • Specific applications included achieving "light sleep," rapid sedation adjustments, and facilitating neurological assessments.

    Related Experiment Videos

    Main Results:

    • Sedation was satisfactory for 86% of the total administration time.
    • No serious complications were associated with alphaxalone-alphadolone use.
    • No tachyphylaxis or delayed recovery was observed, even with infusions lasting up to 20 days.

    Conclusions:

    • Controlled infusion of alphaxalone-alphadolone offers a safe and effective method for sedation in the intensive therapy unit.
    • The technique allows for precise titration and rapid adjustments, enhancing patient management and neurological monitoring.
    • Long-term administration did not lead to tolerance or prolonged recovery, indicating sustained efficacy.